Global Artificial Saliva Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Artificial Saliva Market Research Report 2024
Saliva plays an important role in chewing, swallowing, digesting, and speaking. It also helps control bacteria in your mouth, which helps prevent infection and tooth decay. Artificial saliva can relieve the symptoms of dry mouth and help you avoid health complications.
According to Mr Accuracy reports’s new survey, global Artificial Saliva market is projected to reach US$ 465 million in 2034, increasing from US$ 262.2 million in 2024, with the CAGR of 8.1% during the period of 2023 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Artificial Saliva market research.
The World Health Organization data shows that oral diseases are the fourth-most expensive disease to treat in both emerging and developed economies. Oral health maintenance expenditure is a major healthcare issue directly impacting the artificial saliva market. As the artificial saliva market is consumer-based, increase in disposable income and per-capita spending are likely to drive the artificial saliva market over the course of the forecast period. A critical issue to be resolved before that is the demand-supply imbalance in the artificial saliva market that affects everybody from manufacturers to end consumers. Any supply chain deviation leads to a rise in price, reducing the ability of key players to offer products at competitive prices and boost the overall profile of the artificial saliva market.
Report Scope
This report, based on historical analysis (2018-2024) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Artificial Saliva market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
GlaxoSmithKline
Cipla Limited
Fresenius Kabi
Parnell Pharmaceuticals
Entod International
Forward Science
Biocosmetics Laboratories
Icpa Health Products LTD.
Perrigo
Laboratorios Kin
Segment by Type
Oral Spray
Oral Solution
Oral Liquid
Gel
Powder
Adult
Paediatric
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
The Artificial Saliva report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
According to Mr Accuracy reports’s new survey, global Artificial Saliva market is projected to reach US$ 465 million in 2034, increasing from US$ 262.2 million in 2024, with the CAGR of 8.1% during the period of 2023 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Artificial Saliva market research.
The World Health Organization data shows that oral diseases are the fourth-most expensive disease to treat in both emerging and developed economies. Oral health maintenance expenditure is a major healthcare issue directly impacting the artificial saliva market. As the artificial saliva market is consumer-based, increase in disposable income and per-capita spending are likely to drive the artificial saliva market over the course of the forecast period. A critical issue to be resolved before that is the demand-supply imbalance in the artificial saliva market that affects everybody from manufacturers to end consumers. Any supply chain deviation leads to a rise in price, reducing the ability of key players to offer products at competitive prices and boost the overall profile of the artificial saliva market.
Report Scope
This report, based on historical analysis (2018-2024) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Artificial Saliva market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
GlaxoSmithKline
Cipla Limited
Fresenius Kabi
Parnell Pharmaceuticals
Entod International
Forward Science
Biocosmetics Laboratories
Icpa Health Products LTD.
Perrigo
Laboratorios Kin
Segment by Type
Oral Spray
Oral Solution
Oral Liquid
Gel
Powder
Segment by Application
Adult
Paediatric
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
The Artificial Saliva report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source